What is Curebase?
Curebase is a pioneering healthtech company dedicated to accelerating the delivery of medical innovations to patients and enhancing human well-being through more efficient clinical studies. Founded in 2017 and headquartered in San Francisco, California, Curebase is fundamentally reshaping clinical trials by empowering physicians to enroll patients within their local communities. The company leverages cutting-edge clinical software and remote study management techniques to streamline the research process, marking a significant departure from traditional trial methodologies.
How much funding has Curebase raised?
Curebase has raised a total of $55M across 2 funding rounds:
Series A
$15M
Series B
$40M
Series A (2021): $15M with participation from Xfund, Bold Capital, and GGV Capital
Series B (2022): $40M led by GGV Capital, Positive Sum, Xfund, Industry Ventures, World Innovation Lab, Acrew Capital Management, and BOLD Capital Group
Key Investors in Curebase
GGV Capital
GGV Capital is a global venture firm that invests in early-stage to growth-stage companies across social/internet, enterprise tech, and smart tech sectors. They are known for backing transformative companies worldwide.
Positive Sum
Positive Sum invests in early-stage companies, providing long-term capital and leveraging their network to foster positive outcomes for companies, customers, and investors.
Xfund
Xfund is an early-stage venture capital firm that supports entrepreneurs experimenting across disciplines, often emerging from academic research, and provides strategic value through its unique network.
What's next for Curebase?
The substantial enterprise-level funding Curebase has attracted indicates a strong market validation and positions the company for significant scaling and expansion. This capital infusion is expected to fuel further development of its innovative platform, enhance its operational capabilities, and broaden its market reach. Curebase's strategic approach to decentralized clinical trials suggests a future focused on increasing accessibility, reducing trial timelines, and ultimately bringing life-changing treatments to patients more rapidly.
See full Curebase company page
